Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Targacept, Inc. (NQ: TRGT)
5.480 USD  +0.070 (+1.29%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Targacept, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Recent 52-Week High Exceeded in Shares of Targacept (TRGT)
May 17, 2013
from Comtex SmarTrend® News Briefs
Watch for Continued Gains in Shares of Targacept (TRGT)
May 08, 2013
from Comtex SmarTrend® News Briefs
Targacept, Inc. (TRGT) Bests Q1 Loss Views; Revs Strong
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8310668 for the full story. Read More
from StreetInsider.com News Articles
Targacept Reports First Quarter 2013 Financial Results
May 07, 2013
from Business Wire News Releases
Trading Radar for 05/07: Electronic Arts (EA), DirecTV (DTV), Fossil (FOSL), McKesson (MCK) Report
May 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8309221 for the full story. Read More
from StreetInsider.com News Articles
Targacept to Report First Quarter 2013 Financial Results on May 7, 2013
April 30, 2013
from Business Wire News Releases
Targacept (TRGT) Completes TC-1734 Phase 2b Enrollment
April 29, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8284727 for the full story. Read More
from StreetInsider.com News Articles
Targacept Completes Recruitment in Phase 2b Trial of TC-1734 in Mild to Moderate Alzheimer’s Disease
April 29, 2013
from Business Wire News Releases
Targacept Announces Participation in Upcoming Conferences
April 22, 2013
from Business Wire News Releases
Targacept Completes Recruitment in Phase 2b Schizophrenia Trial of TC-5619
April 18, 2013
Targacept (NASDAQ: TRGT ), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that it has completed recruitment of patients in the Phase 2b study of TC-5619... Read More
category Benzinga , TRGT , News , and 1 more.
from Latest Articles from Benzinga.com
Targacept Completes Recruitment in Phase 2b Schizophrenia Trial of TC-5619
April 18, 2013
from Business Wire News Releases
Targacept directors, senior executive stepping down
March 18, 2013
Jeffrey Brennan, Targacept Inc.'s chief business officer and a ten-year veteran of the company, will step down at the end of this month to pursue other opportunities, according to an announcement from... Read More
from National Business News - Local Business News | bizjournals
Targacept Announces Changes to Board of Directors and Management
March 18, 2013
Targacept (NASDAQ: TRGT ), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced the following changes to its Board of Directors: M. James Barrett, Ph.D.... Read More
category Management , Benzinga , TRGT , and 1 more.
from Latest Articles from Benzinga.com
Targacept (TRGT) Announces Director Resignations, Retirement
March 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8193403 for the full story. Read More
from StreetInsider.com News Articles
Targacept Announces Changes to Board of Directors and Management
March 18, 2013
from Business Wire News Releases
Targacept (TRGT) New CEO Hill Buys 20K Shares
March 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8174643 for the full story. Read More
from StreetInsider.com News Articles
Biotech.Stock Leaders: Targacept, Puma Biotechnology Inc, Sinovac Biotech Ltd, Cambrex Corporation
March 08, 2013
Lakeway, TX -- (SBWIRE) -- 03/08/2013 -- vb-news.net, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following... Read More
from SBWire - Latest Press Releases
Targacept (TRGT) Enters New Modulator Collaboration Agreement w/ AstraZeneca (AZN)
March 05, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8155161 for the full story. Read More
from StreetInsider.com News Articles
Targacept and AstraZeneca Amend Collaboration
March 05, 2013
from Business Wire News Releases
Targacept Inc Becomes Oversold (TRGT)
March 04, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category Stocks
from Market News Video
(SGEN) Seattle Genetics Starts SGN-CD19A Phase I Study
February 27, 2013
Seattle Genetics Inc. (SGEN) recently commenced two phase I clinical studies with its oncology... Visit StockBlogHub to view complete post. Read More
category SGEN , PPHM , Hecla Mining Company , and 13 more.
from Stock Blog Hub
Targacept to Present at the Cowen and Company 33rd Annual Health Care Conference
February 26, 2013
from Business Wire News Releases
5 Biotechnology Stocks to Sell Now
February 20, 2013
 Read More
category NASDAQ:TRGT , NASDAQ:CBST , Stocks to Sell , and 3 more.
from InvestorPlace - Latest Headlines
(SGEN) Seattle Genetics’ Adcetris Earns Approval from Health Canada
February 17, 2013
Seattle Genetics Inc. (SGEN) recently received approval from Health Canada for its oncology drug,... Visit StockBlogHub to view complete post. Read More
category SGEN , PPHM , Hecla Mining Company , and 9 more.
from Stock Blog Hub
Earnings Review: Skechers USA Inc., Smith Micro Software, Inc., Tangoe Inc, Targacept, Inc.
February 14, 2013
Lakeway, NY -- (SBWIRE) -- 02/14/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... Read More
from SBWire - Latest Press Releases
Targacept, Inc. (TRGT) Misses Q4 EPS by 16c
February 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8092987 for the full story. Read More
from StreetInsider.com News Articles
Targacept Reports Fourth Quarter and 2012 Financial Results
February 13, 2013
from Business Wire News Releases
Biotech Stocks Alert (Targacept, Santarus, Array Biopharma Inc, Amyris Inc)
February 13, 2013
Las Vegas, NV -- (SBWIRE) -- 02/13/2013 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume leaders as reported by Beststocksdaily. Read More
from SBWire - Latest Press Releases
Trading Radar for 02/13: Cisco (CSCO), NVIDIA (NVDA), Deere & Co. (DE), Liberty Global (LBTYA), Zillow (Z) Report
February 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8087408 for the full story. Read More
from StreetInsider.com News Articles
Targacept to Report Fourth Quarter and 2012 Financial Results on February 13, 2013
February 06, 2013
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here